ÂÜÀòÂÒÂ×

Ahmad provides strategic insight on clinical trial design across several therapeutic areas, including cardiometabolic, hematology, oncology, and rare diseases. Ahmad’s more than 14 years of experience in both the pharmaceutical industry and academic research includes positions at Wellmera and the Global Market Access Cardio-Metabolic franchise of Novartis Global. Ahmad holds a PhD in Genetics and Neuroscience from the University of Claude Bernard in Lyon.